Description: An article from The Actuary that highlights the strategic importance of inter-company mortality studies. Broad-based mortality studies form the backbone of the life actuarial profession. However, few companies have sufficient exposure or deaths to construct their own mortality table. Even is some large companies have enough data, there is still a vast majority of companies that do not. Historically, the void has been filled by means of inter-company studies.

Description: Future mortality improvement has been a common assumption in life insurance and annuity pricing and forecasting for many years. However, experience over the last decade suggests this might be an assumption that merits reconsideration in the United States. This article will take a closer look at factors that impact mortality improvement trends and discuss why insurers may want to reevaluate product designs to better manage the associated mortality risk. We then introduce a product idea with this in mind, where premiums are based on a life expectancy index and insurers share the risk (and opportunity) or mortality improvement with policyholders.